New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 13, 2026

Back to the front page

From X

@Mr_Neutral_Man

Mr Neutral Man aka "Howard Marks of REITs” on X

SFR REIT VineBrook Stops Buybacks, Flags Upcoming Maturities @LeylaKuni I talk about REITs because stuff like this happens. VineBrook is a nontraded REIT which claims a NAV of $50 but tenders for shares at $33/share. Average home is expected to sell for $129k each. You can get Single Family Home Exposure by buying $INVH which is operating from a position of strength by selling homes between $300k/home to $600k/home to buy back their stock trading at $270k/home. Pays a dividend of 4.5%, covers interest payment 4.1 times, and bought back $1 billion of shares since Q4 of 2025 or roughly 6.1% of the S/O. I think shares are worth $37 to $50 and you can buy shares for $26/27!!! ********************************* From Bisnow The nontraded single-family rental home REIT also disclosed that it has $650.8M of debt maturing within a year, and it doesn’t have liquidity to satisfy those obligations, AltsWire reported. VineBrook owned about 20,500 single-family rental homes in 21 states as of Sept. 30. Its occupancy fell from 94.7% to 93.5% year-over-year, but its average monthly rent rose from $1,339 to $1,460, AltsWire reported. The REIT’s board approved a change to stop processing share repurchase requests on Oct. 26, three weeks after completing the $30M tender offer at $33 a share. That was 34% below the per-share net asset value of about $50 on Sept. 30. The $30M would buy about 909,000 shares, but about 2.75 million shares were tendered but not withdrawn before the offer expired Oct. 5. The REIT said shares not purchased would be returned. The tender offer was VineBrook's first broad liquidity opportunity since it suspended its share repurchase plan in December 2022, except in cases of death, disability or similar hardship, AltsWire reported. The new share buyback halt doesn’t include those exceptions. VineBrook also disclosed that it has two MetLife notes that will mature in March and August, a JPMorgan Chase acquisition facility maturing in July, and convertible notes maturing in June, all contributing to the $650.8M of debt coming due within a year. The company is in discussions with potential lenders and expects to refinance the MetLife loans before maturity. Options to satisfy the obligations include partial loan paydowns, using extension options and selling homes. It has a one-year extension option on the JPMorgan facility. VineBrook plans over the next year to sell about 2,700 homes in its main portfolio for roughly $348M and sell 1,050 homes in its NextPoint Homes portfolio for about $284M. The REIT sold more than 2,300 homes between its two portfolios during the first nine months of this year, generating about $351M. Pretium Partners, another SFR company that manages more than 90,000 homes, agreed this week to pay $49.7M to settle charges from the Federal Trade Commission regarding misleading rental pricing practices. Blackstone Real Estate Income Trust, or BREIT, wrote down $496.7M tied to 14 commercial properties and various single-family homes during Q3, up significantly from $27.4M over the same period a year earlier.
@aleabitoreddit

Serenity on X

I personally love $AXTI here, even after I watched my position round trip $13 -> $140 -> $45. $100m->$500m in near term backlog driven by ordinary near term orders Annualized P/E compressed down to 18.8x Q4, before 2027 capacity expansion and price hikes. Now with confirmed counterparty visibility with $LITE and $COHR (before it was speculation). Of course China risk is always a wildcard, especially with the $NVDA scandals + China hawks in Washington. But fundamentally, it’s been in its best shape ever and I’m proud watching AXT grow up
@aleabitoreddit

Serenity on X

Good question! $SIVE pre-2026 targeted custom CPO deployments like Ayar. Many of these architecturally were pushed back to 2028. Only Q3 2025, did Sivers shift to mass commercialization products, with 7 new pluggable players, including $JBL H1 2026. Sivers is also sampling NPO 200mW lasers with a series of players and hints at future 400mW capabilities for CPO. Since Sivers previously focused on custom scale up CPO players, then only recently applied their technology to near term pluggables and NPO commercialzable opportunities. They missed a lot of deployment windows others are capitalizing on now. But I think everything comes together H2 2027. I think optical TAM keeps exponentially increasing into 2030, so even if they missed 2026 or early 2027 deployments… market capture opportunity is very large relative to valuations $SIVE in my opinion is the golden goose of optical opportunities but it all comes down to to management execution, which has been slightly disappointing as of recent.
@aleabitoreddit

Serenity on X

Following the $MRVL and $LITE acquisition announcement… Samsung Electronics has been doing vertical integration of their own in photonics to thermal: - New report from Bloomberg states that Samsung Electronics is in talks to buy $MOD Modine. Which supplies thermal/cooling infrastructure for AI data centers. - 2 days ago from Digitimes, Samsung has purchased series of silicon photonics patents from Rockley Photonics (that previously was bankrupt). Covering modulators and PICs, mainly around design and integration. This follows earlier leaks that “Samsung is reportedly considering acquisitions in the silicon photonics space” After Samsung’s reportedly pursues optical engine and PIC manufacturing by 2027, and CPO services by 2029. We’ll likely see this trend accelerate with M&A vertical integration across AI supply chains. Especially considering valuations from smaller upstream companies collapsed recently, despite their strategic significance.

Investor Letters

All letters

QXO Inc Earnings Update: Q3 2026

QXO's Q3 sales rose 79% to $4.9 billion after TopBuild and Kodiak acquisitions, while acquisition debt lifted interest expense to $163…

QXO $13B
SixSigmaCapital: Navigating the Financial Markets 2 clicks

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

QURE $1.7B
Triple S Special Situations Investing 2 clicks
HKTGF · long

Hikari Tsushin INC

Hikari Tsushin compounded shareholder equity at 17% annually over 15 years while its shares declined modestly in the past year.

HKTGF $11B
Value Investors Club

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $116B
Cestrian Capital Research 1 click

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.9T
Cestrian Capital Research 3 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 84 of 289

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.